Agile Therapeutics, Inc. (AGRX)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
29-Aug-22 8:30 AM
View: 
Altomari Alfred
Chief Executive Officer
Director
Agile Therapeutics, Inc. (AGRX) 26-Aug-22Market Purchase 50,000$0.45$22,500.00349%
14.34K to 64.34K
(11%)
10-Jun-22 4:46 PM
View: 
Shetty Ajit
Director
Agile Therapeutics, Inc. (AGRX) 09-Jun-22Grant 670----43%
1.57K to 2.24K
10-Jun-22 4:47 PM
View: 
Fischer Seth H.Z.
Director
Agile Therapeutics, Inc. (AGRX) 09-Jun-22Grant 670----48%
1.4K to 2.07K
10-Jun-22 4:45 PM
View: 
Tursi James Patrick
Director
Agile Therapeutics, Inc. (AGRX) 09-Jun-22Grant 670----48%
1.4K to 2.07K
10-Jun-22 4:49 PM
View: 
Barbari Sharon Surrey
Director
Agile Therapeutics, Inc. (AGRX) 09-Jun-22Grant 670----52%
1.28K to 1.95K
10-Jun-22 4:48 PM
View: 
Carson Sandra
Director
Agile Therapeutics, Inc. (AGRX) 09-Jun-22Grant 670----52%
1.28K to 1.95K
10-Jun-22 4:45 PM
View: 
Torrente Josephine
Director
Agile Therapeutics, Inc. (AGRX) 09-Jun-22Grant 670----34%
1.99K to 2.66K
10-Jun-22 4:47 PM
View: 
Hubbard John W
Director
Agile Therapeutics, Inc. (AGRX) 09-Jun-22Grant 670----48%
1.4K to 2.07K
15-Oct-21 4:05 PM
View: 
Perceptive Advisors LLC
10% Owner
Agile Therapeutics, Inc. (AGRX) 13-Oct-21Market Purchase 5,734,560$0.85$4,874,380.0036%
15.92M to 21.65M
(10%)
14-Oct-21 8:01 AM
View: 
Reilly Dennis
Chief Financial Officer
Agile Therapeutics, Inc. (AGRX) 13-Oct-21Purchase 58,824----23%
251.31K to 310.13K
14-Oct-21 8:00 AM
View: 
Altomari Alfred
Chief Executive Officer
Director
Agile Therapeutics, Inc. (AGRX) 13-Oct-21Purchase 58,824----11%
514.91K to 573.73K
08-Oct-21 5:03 PM
View: 
Torrente Josephine
Director
Agile Therapeutics, Inc. (AGRX) 07-Oct-21Grant 79,593----100%
0 to 79.59K
29-Jul-21 7:52 PM
View: 
Altomari Alfred
Chief Executive Officer
Director
Agile Therapeutics, Inc. (AGRX) 29-Jul-21Market Purchase 26,200$1.26$33,095.805%
488.71K to 514.91K
(41%)
28-Jul-21 8:57 PM
View: 
Reilly Dennis
Chief Financial Officer
Agile Therapeutics, Inc. (AGRX) 27-Jul-21Market Purchase 50,000$1.08$54,145.0025%
201.31K to 251.31K
(31%)
10-Jun-21 7:08 PM
View: 
Tursi James Patrick
Director
Agile Therapeutics, Inc. (AGRX) 08-Jun-21Grant 24,510----78%
31.34K to 55.85K
10-Jun-21 7:11 PM
View: 
Barbari Sharon Surrey
Director
Agile Therapeutics, Inc. (AGRX) 08-Jun-21Grant 24,510----92%
26.79K to 51.3K
11-Jun-21 5:55 PM
View: 
Carson Sandra
Director
Agile Therapeutics, Inc. (AGRX) 08-Jun-21Grant 24,510----92%
26.79K to 51.3K
10-Jun-21 7:12 PM
View: 
Hubbard John W
Director
Agile Therapeutics, Inc. (AGRX) 08-Jun-21Grant 24,510----78%
31.34K to 55.85K
10-Jun-21 7:10 PM
View: 
Shetty Ajit
Director
Agile Therapeutics, Inc. (AGRX) 08-Jun-21Grant 24,510----64%
38.34K to 62.85K
10-Jun-21 7:13 PM
View: 
Fischer Seth H.Z.
Director
Agile Therapeutics, Inc. (AGRX) 08-Jun-21Grant 24,510----78%
31.34K to 55.85K
19-May-21 8:30 AM
View: 
Altomari Alfred
Chief Executive Officer
Director
Agile Therapeutics, Inc. (AGRX) 18-May-21Market Purchase 20,000$1.61$32,200.004%
468.71K to 488.71K
(54%)
12-May-21 4:31 PM
View: 
Reilly Dennis
Chief Financial Officer
Agile Therapeutics, Inc. (AGRX) 11-May-21Market Purchase 20,000$1.35$27,000.0011%
181.31K to 201.31K
(45%)
30-Mar-21 4:48 PM
View: 
Butch Jason
Principal Accounting Officer
Agile Therapeutics, Inc. (AGRX) 29-Mar-21Market Purchase 1,358$1.99$2,702.427%
18.64K to 20.0K
(62%)
30-Mar-21 4:48 PM
View: 
Butch Jason
Principal Accounting Officer
Agile Therapeutics, Inc. (AGRX) 26-Mar-21Market Purchase 8,642$2.01$17,370.4086%
10.0K to 18.64K
(63%)
23-Mar-21 5:23 PM
View: 
Reilly Dennis
Chief Financial Officer
Agile Therapeutics, Inc. (AGRX) 23-Mar-21Market Purchase 50,000$2.05$102,500.0038%
131.31K to 181.31K
(63%)
23-Mar-21 5:24 PM
View: 
Altomari Alfred
Chief Executive Officer
Director
Agile Therapeutics, Inc. (AGRX) 23-Mar-21Market Purchase 12,500$2.00$25,030.003%
456.21K to 468.71K
(63%)
28-Jan-21 6:34 PM
View: 
Conway Robert G
SVP Chief Supply Chain Officer
Agile Therapeutics, Inc. (AGRX) 27-Jan-21Grant 35,461----155%
22.9K to 58.36K
23-Nov-20 5:00 PM
View: 
Conway Robert G
SVP Chief Supply Chain Officer
Agile Therapeutics, Inc. (AGRX) 19-Nov-20Option Exercise 4,149$1.76$7,302.2422%
18.75K to 22.9K
28-Sep-20 4:10 PM
View: 
Reilly Dennis
Chief Financial Officer
Agile Therapeutics, Inc. (AGRX) 28-Sep-20Market Purchase 9,000$2.85$25,650.007%
122.31K to 131.31K
(74%)
26-Aug-20 5:00 PM
View: 
Reilly Dennis
Chief Financial Officer
Agile Therapeutics, Inc. (AGRX) 26-Aug-20Grant 37,500$1.01$37,875.0044%
84.81K to 122.31K
20-Aug-20 4:15 PM
View: 
Altomari Alfred
Chief Executive Officer
Director
Agile Therapeutics, Inc. (AGRX) 20-Aug-20Option Exercise 94,599$1.76$166,494.0026%
361.61K to 456.21K
23-Jun-20 5:00 PM
View: 
Altomari Alfred
Chief Executive Officer
Director
Agile Therapeutics, Inc. (AGRX) 22-Jun-20Option Exercise 50,000$1.76$88,000.0016%
311.61K to 361.61K
11-Jun-20 5:20 PM
View: 
Barbari Sharon Surrey
Director
Agile Therapeutics, Inc. (AGRX) 09-Jun-20Grant 26,786----100%
0 to 26.79K
11-Jun-20 5:21 PM
View: 
Carson Sandra
Director
Agile Therapeutics, Inc. (AGRX) 09-Jun-20Grant 26,786----100%
0 to 26.79K
11-Jun-20 5:22 PM
View: 
Fischer Seth H.Z.
Director
Agile Therapeutics, Inc. (AGRX) 09-Jun-20Grant 13,393----75%
17.95K to 31.34K
11-Jun-20 5:22 PM
View: 
Tursi James Patrick
Director
Agile Therapeutics, Inc. (AGRX) 09-Jun-20Grant 13,393----75%
17.95K to 31.34K
11-Jun-20 5:21 PM
View: 
Shetty Ajit
Director
Agile Therapeutics, Inc. (AGRX) 09-Jun-20Grant 13,393----54%
24.95K to 38.34K
11-Jun-20 5:21 PM
View: 
Hubbard John W
Director
Agile Therapeutics, Inc. (AGRX) 09-Jun-20Grant 13,393----75%
17.95K to 31.34K
16-Mar-20 4:30 PM
View: 
Gilmore Geoffrey
General Counsel
Agile Therapeutics, Inc. (AGRX) 13-Mar-20Grant 25,500$1.56$39,780.0046%
55.78K to 81.28K
(52%)
17-Mar-20 3:50 PM
View: 
Perceptive Advisors LLC
10% Owner
Agile Therapeutics, Inc. (AGRX) 13-Mar-20Market Purchase 1,000,000$1.75$1,750,000.007%
14.92M to 15.92M
(57%)
06-Mar-20 8:00 AM
View: 
Reilly Dennis
Chief Financial Officer
Agile Therapeutics, Inc. (AGRX) 04-Mar-20Market Purchase 50,000$2.32$116,000.00510%
9.81K to 59.81K
(68%)
06-Mar-20 8:00 AM
View: 
Reilly Dennis
Chief Financial Officer
Agile Therapeutics, Inc. (AGRX) 04-Mar-20Market Purchase 25,000$2.35$58,750.0042%
59.81K to 84.81K
(68%)
27-Feb-20 9:27 PM
View: 
Altomari Alfred
Chief Executive Officer
Director
Agile Therapeutics, Inc. (AGRX) 27-Feb-20Market Purchase 10,000$2.71$27,100.003%
301.61K to 311.61K
(72%)
27-Feb-20 9:27 PM
View: 
Altomari Alfred
Chief Executive Officer
Director
Agile Therapeutics, Inc. (AGRX) 27-Feb-20Option Exercise 16,541$0.71$11,744.106%
285.07K to 301.61K
25-Feb-20 8:10 PM
View: 
Perceptive Advisors LLC
10% Owner
Agile Therapeutics, Inc. (AGRX) 25-Feb-20Market Purchase 3,000,000$3.00$9,000,000.0025%
11.92M to 14.92M
(75%)
24-Jan-20 7:59 PM
View: 
Reilly Dennis
Chief Financial Officer
Agile Therapeutics, Inc. (AGRX) 22-Jan-20Grant 9,806----100%
0 to 9.81K
24-Jan-20 7:59 PM
View: 
Altomari Alfred
Chief Executive Officer
Director
Agile Therapeutics, Inc. (AGRX) 22-Jan-20Grant 26,502----10%
258.57K to 285.07K
24-Jan-20 7:59 PM
View: 
Conway Robert G
Sr. VP Manufacturing & Supply
Agile Therapeutics, Inc. (AGRX) 22-Jan-20Grant 6,272----100%
6.28K to 12.55K
24-Jan-20 8:00 PM
View: 
Gilmore Geoffrey
General Counsel
Agile Therapeutics, Inc. (AGRX) 22-Jan-20Grant 10,071----22%
45.71K to 55.78K
18-Nov-19 7:00 PM
View: 
Perceptive Advisors LLC
10% Owner
Agile Therapeutics, Inc. (AGRX) 15-Nov-19Market Purchase 5,333,800$1.68$8,940,810.0081%
6.59M to 11.92M
(55%)